Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00418535
Status:
COMPLETED
Last Update Posted:
2009-10-21
First Post:
2007-01-03
Brief Title:
Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer NKT-cell Lymphoma
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
A Phase II Study of Concurrent Chemoradiation Followed by VIPD EtoposideIfosfamideCisplatinDexamethasone in Stage I II Nasal NKT-cell Lymphoma
Status:
COMPLETED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Nasal NKT-cell lymphoma is a peculiar clinico-pathologic subtype of non-Hodgkins lymphoma NHL Although most patients present with stage III only 30-60 of the patients remain disease-free The efficacy of the conventional anthracycline-based chemotherapy cyclophosphamide doxorubicin vincristine prednisone CHOPP has been unsatisfactory
The optimal treatment of localized NKT-cell lymphoma has not been defined yet The optimal dose sequence and multi-modality treatment with involved field radiotherapy still need to be refined This trial is to evaluate the efficacy of concurrent chemoradiotherapy with cisplatin followed by VIPD etoposide ifosfamide cisplatin dexamethasone in localized NKT-cell lymphoma patients
The optimal treatment of localized NKT-cell lymphoma has not been defined yet The optimal dose sequence and multi-modality treatment with involved field radiotherapy still need to be refined This trial is to evaluate the efficacy of concurrent chemoradiotherapy with cisplatin followed by VIPD etoposide ifosfamide cisplatin dexamethasone in localized NKT-cell lymphoma patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None